Collapsing glomerulopathy in systemic lupus erythematosus

Kerolos Abadeer, Ali A. Alsaad, Xochiquetzal J. Geiger, Ivan Porter

Research output: Contribution to journalArticle

Abstract

Collapsing glomerulopathy (CG) is a rare disease that can be associated with multiple other disorders. It usually leads to poor prognosis with a high percentage of patients progressing to end-stage renal disease. In this article, we illustrate a clinical case of CG associated with systemic lupus erythematosus that had a prompt response to mycophenolate and prednisone. The condition started after sudden cessation of the already established mycophenolate treatment regimen. The patient then presented with acute kidney injury due to kidney biopsy-proven CG. In that circumstance, we hypothesised that mycophenolate may play a role in prevention and development of CG.

Original languageEnglish (US)
JournalBMJ Case Reports
Volume2017
DOIs
StatePublished - 2017

Fingerprint

Systemic Lupus Erythematosus
Rare Diseases
Prednisone
Acute Kidney Injury
Chronic Kidney Failure
Kidney
Biopsy
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Collapsing glomerulopathy in systemic lupus erythematosus. / Abadeer, Kerolos; Alsaad, Ali A.; Geiger, Xochiquetzal J.; Porter, Ivan.

In: BMJ Case Reports, Vol. 2017, 2017.

Research output: Contribution to journalArticle

Abadeer, Kerolos ; Alsaad, Ali A. ; Geiger, Xochiquetzal J. ; Porter, Ivan. / Collapsing glomerulopathy in systemic lupus erythematosus. In: BMJ Case Reports. 2017 ; Vol. 2017.
@article{62e39cdd4feb4c0e96f9c793d6df05a9,
title = "Collapsing glomerulopathy in systemic lupus erythematosus",
abstract = "Collapsing glomerulopathy (CG) is a rare disease that can be associated with multiple other disorders. It usually leads to poor prognosis with a high percentage of patients progressing to end-stage renal disease. In this article, we illustrate a clinical case of CG associated with systemic lupus erythematosus that had a prompt response to mycophenolate and prednisone. The condition started after sudden cessation of the already established mycophenolate treatment regimen. The patient then presented with acute kidney injury due to kidney biopsy-proven CG. In that circumstance, we hypothesised that mycophenolate may play a role in prevention and development of CG.",
author = "Kerolos Abadeer and Alsaad, {Ali A.} and Geiger, {Xochiquetzal J.} and Ivan Porter",
year = "2017",
doi = "10.1136/bcr-2016-217840",
language = "English (US)",
volume = "2017",
journal = "BMJ Case Reports",
issn = "1757-790X",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Collapsing glomerulopathy in systemic lupus erythematosus

AU - Abadeer, Kerolos

AU - Alsaad, Ali A.

AU - Geiger, Xochiquetzal J.

AU - Porter, Ivan

PY - 2017

Y1 - 2017

N2 - Collapsing glomerulopathy (CG) is a rare disease that can be associated with multiple other disorders. It usually leads to poor prognosis with a high percentage of patients progressing to end-stage renal disease. In this article, we illustrate a clinical case of CG associated with systemic lupus erythematosus that had a prompt response to mycophenolate and prednisone. The condition started after sudden cessation of the already established mycophenolate treatment regimen. The patient then presented with acute kidney injury due to kidney biopsy-proven CG. In that circumstance, we hypothesised that mycophenolate may play a role in prevention and development of CG.

AB - Collapsing glomerulopathy (CG) is a rare disease that can be associated with multiple other disorders. It usually leads to poor prognosis with a high percentage of patients progressing to end-stage renal disease. In this article, we illustrate a clinical case of CG associated with systemic lupus erythematosus that had a prompt response to mycophenolate and prednisone. The condition started after sudden cessation of the already established mycophenolate treatment regimen. The patient then presented with acute kidney injury due to kidney biopsy-proven CG. In that circumstance, we hypothesised that mycophenolate may play a role in prevention and development of CG.

UR - http://www.scopus.com/inward/record.url?scp=85014043484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014043484&partnerID=8YFLogxK

U2 - 10.1136/bcr-2016-217840

DO - 10.1136/bcr-2016-217840

M3 - Article

C2 - 28242801

AN - SCOPUS:85014043484

VL - 2017

JO - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

ER -